Ophthalmic Artery Chemosurgery for Less Advanced Intraocular Retinoblastoma: Five Year Review

• David H. Abramson ,

  * E-mail: abramsod@mskcc.org

  Affiliation Ophthalmic Oncology Service, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America

  ⨯
• Brian P. Marr,

  Affiliation Ophthalmic Oncology Service, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America

  ⨯
• Scott E. Brodie,

  Affiliations Ophthalmic Oncology Service, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America, Department of Ophthalmology, Mount Sinai School of Medicine, New York, New York, United States of America

  ⨯
• Ira Dunkel,

  Affiliation Department of Pediatrics, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America

  ⨯
• Sotiria Palioura,

  Affiliations Ophthalmic Oncology Service, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America, Department of Ophthalmology, Massachusetts Eye and Ear Infirmary, Boston, Massachusetts, United States of America

  ⨯
• Y. Pierre Gobin

  Affiliation Departments of Radiology and Neurosurgery, Weill Cornell Medical College, New York, New York, United States of America

  ⨯